FIELD: medicine.
SUBSTANCE: present invention refers to medicine, namely to therapy and neurology, and concerns alleviating the symptoms associated with such cranial nerves as trigeminal, facial, glossopharyngeal or vagal. For this purpose, a pharmaceutical composition containing an analgesic and an anesthetic is introduced into the external auditory canal.
EFFECT: it provides reduction of painful sensations after tonzillotomy and adenoidectomy, relief of asthma attacks, neurogenic cough and other symptoms due to local auricular anesthesia and blocking of transfer of afferent and efferent signals transferred through the specified nerves.
8 cl, 7 dwg, 9 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING AURICULAR PAIN BY ANESTHESIA OF CRANIAL NERVES | 2016 |
|
RU2701548C1 |
| METHOD OF SNORE TREATMENT | 2009 |
|
RU2410133C1 |
| METHOD OF BODY EXPOSURE | 2012 |
|
RU2502528C1 |
| DIBENZO-AZEPINE COMPOUNDS AND USE THEREOF FOR TREATING EAR DISEASES AND DISORDERS | 2016 |
|
RU2707284C1 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
| PHARMACEUTICAL COMPOSITION INCLUDING PLATELET-RICH-PLASMA AND INTENDED FOR PREVENTION OR TREATING SENSORINEURAL HEARING LOSS OR TINNITUS AND METHOD USING THE SAME | 2016 |
|
RU2657828C2 |
| CYSTATHIONINE-γ-LYASE (CSE) INHIBITORS | 2013 |
|
RU2661879C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PLASMA ENRICHED WITH THROMBOCYTES AND INTENDED FOR PREVENTION OR TREATMENT OF NEUROSENSORY HEARING LOSS OR NOISE IN EARS, AND METHOD OF ITS APPLICATION | 2016 |
|
RU2720511C2 |
| METHOD OF TREATING PATIENTS WITH DEAFNESS | 2008 |
|
RU2393838C1 |
| SYSTEMS AND METHODS FOR STIMULATION OF NEURONAL ACTIVITY | 2010 |
|
RU2558459C2 |
